BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23704076)

  • 1. Delineation of a new chromosome 20q11.2 duplication syndrome including the ASXL1 gene.
    Avila M; Kirchhoff M; Marle N; Hove HD; Chouchane M; Thauvin-Robinet C; Masurel A; Mosca-Boidron AL; Callier P; Mugneret F; Kjaergaard S; Faivre L
    Am J Med Genet A; 2013 Jul; 161A(7):1594-8. PubMed ID: 23704076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of CD96 and ASXL1 in 11 patients with Opitz C or Bohring-Opitz syndromes.
    Urreizti R; Roca-Ayats N; Trepat J; Garcia-Garcia F; Aleman A; Orteschi D; Marangi G; Neri G; Opitz JM; Dopazo J; Cormand B; Vilageliu L; Balcells S; Grinberg D
    Am J Med Genet A; 2016 Jan; 170A(1):24-31. PubMed ID: 26768331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel patients with Bohring-Opitz syndrome caused by de novo ASXL1 mutations.
    Magini P; Della Monica M; Uzielli ML; Mongelli P; Scarselli G; Gambineri E; Scarano G; Seri M
    Am J Med Genet A; 2012 Apr; 158A(4):917-21. PubMed ID: 22419483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel truncating mutations in ASXL1 identified in two boys with Bohring-Opitz syndrome.
    Zhao J; Hou Y; Fang F; Ding C; Yang X; Li J; Cui D; Cao Z; Zhang H
    Eur J Med Genet; 2021 Mar; 64(3):104155. PubMed ID: 33529703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bohring-Opitz syndrome caused by an ASXL1 mutation inherited from a germline mosaic mother.
    Bedoukian E; Copenheaver D; Bale S; Deardorff M
    Am J Med Genet A; 2018 May; 176(5):1249-1252. PubMed ID: 29681100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel de-novo frameshift mutation of the ASXL1 gene in a classic case of Bohring-Opitz syndrome.
    Arunachal G; Danda S; Omprakash S; Kumar S
    Clin Dysmorphol; 2016 Jul; 25(3):101-5. PubMed ID: 27043953
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz Syndrome.
    Carlston CM; O'Donnell-Luria AH; Underhill HR; Cummings BB; Weisburd B; Minikel EV; Birnbaum DP; ; Tvrdik T; MacArthur DG; Mao R
    Hum Mutat; 2017 May; 38(5):517-523. PubMed ID: 28229513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial duplication of 20q11.22q13.11: A case report and review of literature.
    Goetzinger L; Starks RD; Dillahunt K; Major H; Nagy JM; Sidhu A
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1755. PubMed ID: 34268909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel splicing mutation in the ASXL3 gene causing Bainbridge-Ropers syndrome.
    Hori I; Miya F; Ohashi K; Negishi Y; Hattori A; Ando N; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Saitoh S
    Am J Med Genet A; 2016 Jul; 170(7):1863-7. PubMed ID: 27075689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance.
    Russell B; Johnston JJ; Biesecker LG; Kramer N; Pickart A; Rhead W; Tan WH; Brownstein CA; Kate Clarkson L; Dobson A; Rosenberg AZ; Vergano SA; Helm BM; Harrison RE; Graham JM
    Am J Med Genet A; 2015 Sep; 167A(9):2122-31. PubMed ID: 25921057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the phenotypic spectrum of ASXL-related disease: Ten cases and a review of the literature.
    Cuddapah VA; Dubbs HA; Adang L; Kugler SL; McCormick EM; Zolkipli-Cunningham Z; Ortiz-González XR; McCormack S; Zackai E; Licht DJ; Falk MJ; Marsh ED
    Am J Med Genet A; 2021 Jun; 185(6):1700-1711. PubMed ID: 33751773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending the phenotypic spectrum of Bohring-Opitz syndrome: Mild case confirmed by functional studies.
    Leon E; Diaz J; Castilla-Vallmanya L; Grinberg D; Balcells S; Urreizti R
    Am J Med Genet A; 2020 Jan; 182(1):201-204. PubMed ID: 31692235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.
    Hoischen A; van Bon BW; Rodríguez-Santiago B; Gilissen C; Vissers LE; de Vries P; Janssen I; van Lier B; Hastings R; Smithson SF; Newbury-Ecob R; Kjaergaard S; Goodship J; McGowan R; Bartholdi D; Rauch A; Peippo M; Cobben JM; Wieczorek D; Gillessen-Kaesbach G; Veltman JA; Brunner HG; de Vries BB
    Nat Genet; 2011 Jun; 43(8):729-31. PubMed ID: 21706002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome.
    Dangiolo SB; Wilson A; Jobanputra V; Anyane-Yeboa K
    Am J Med Genet A; 2015 Dec; 167A(12):3161-6. PubMed ID: 26364555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A
    Efthymiou S; Salpietro V; Pironti E; Bonsignore M; Ferrazzoli V; Rosa GD; Houlden H
    J Genet; 2019 Dec; 98():. PubMed ID: 31819025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bohring-Opitz syndrome caused by a novel ASXL1 mutation (c.3762delT) in an IVF baby: A case report.
    Wang D; Yuan X; Guo H; Yan S; Wang G; Wang Y; Wang T; He J; Peng X
    Medicine (Baltimore); 2022 Feb; 101(5):e28759. PubMed ID: 35119035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A girl with metopic synostosis and trisomy 13 mosaicism: case report and review of the literature.
    Aypar E; Yildirim MS; Sert A; Ciftci I; Odabas D
    Am J Med Genet A; 2011 Mar; 155A(3):638-41. PubMed ID: 21344634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems.
    Williams SR; Aldred MA; Der Kaloustian VM; Halal F; Gowans G; McLeod DR; Zondag S; Toriello HV; Magenis RE; Elsea SH
    Am J Hum Genet; 2010 Aug; 87(2):219-28. PubMed ID: 20691407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternally inherited autosomal dominant intellectual disability caused by 16p13.3 microduplication.
    Lee CG; Cho E; Ahn YM
    Eur J Med Genet; 2016 Apr; 59(4):210-4. PubMed ID: 26873618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.
    Shashi V; Pena LD; Kim K; Burton B; Hempel M; Schoch K; Walkiewicz M; McLaughlin HM; Cho M; Stong N; Hickey SE; Shuss CM; ; Freemark MS; Bellet JS; Keels MA; Bonner MJ; El-Dairi M; Butler M; Kranz PG; Stumpel CT; Klinkenberg S; Oberndorff K; Alawi M; Santer R; Petrovski S; Kuismin O; Korpi-Heikkilä S; Pietilainen O; Aarno P; Kurki MI; Hoischen A; Need AC; Goldstein DB; Kortüm F
    Am J Hum Genet; 2016 Oct; 99(4):991-999. PubMed ID: 27693232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.